001     304985
005     20251107153958.0
024 7 _ |a 10.1021/acs.jproteome.4c00982
|2 doi
024 7 _ |a pmid:41002257
|2 pmid
024 7 _ |a 1535-3893
|2 ISSN
024 7 _ |a 1535-3907
|2 ISSN
024 7 _ |a altmetric:181725064
|2 altmetric
037 _ _ |a DKFZ-2025-01976
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Biswas, Deeptarup
|b 0
245 _ _ |a BrainProt v3.0: An Integrative and Simplified Omics-Based Knowledge-Base About the Human Brain and Its Associated Diseases.
260 _ _ |a Washington, DC
|c 2025
|b ACS Publications
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1762526365_1834966
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Nov 7;24(11):5352-5369
520 _ _ |a The advancements in neuroscience research and omics technologies generate extensive data for brain-related diseases and disorders that are scattered across various manuscript repositories and databases, potentially hindering global initiatives to advance neuroscience research. This study introduces BrainProt v3.0 (https://www.brainprot.org/), an omics-driven knowledge-base of human brain and associated diseases. BrainProt version 3.0 navigates the Human Brain Disease Atlas (HBDA) and integrates the Brain Disease Marker Curator (BDMC) and Brain Disease Drug Finder (BDDF). It features 20,202 disease-associated genes, 136,557 chemical target interactions, and 2,145 clinical trial details. Additionally, the Brain Disease Transcriptome Map (BDTM) and Brain Disease Proteome Map (BDPM) collate multiomics data from the most significant brain diseases, displaying an expression profile across 52 datasets and 1,868 samples. This platform also facilitates the exploration of biological cross-talk and correlations between transcriptomics and proteomics data to identify critical disease-associated markers. In conclusion, BrainProt is designed to advance the Human Brain Proteome Project (HBPP) by expanding the integration of diseases and datasets, thereby elucidating the complexities of brain diseases and enhancing the research on the interplay between brain tumors and neurodegenerative disorders.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a biomarkers
|2 Other
650 _ 7 |a brain tumors
|2 Other
650 _ 7 |a clinical trials
|2 Other
650 _ 7 |a human brain
|2 Other
650 _ 7 |a neurodegenerative diseases
|2 Other
650 _ 7 |a proteomics
|2 Other
650 _ 7 |a transcriptomics
|2 Other
700 1 _ |a Shenoy, Sanjyot Vinayak
|0 0000-0002-4165-9739
|b 1
700 1 _ |a Chauhan, Aparna
|b 2
700 1 _ |a Halder, Ankit
|b 3
700 1 _ |a Padhye, Advait
|b 4
700 1 _ |a Dutta, Sampurna
|b 5
700 1 _ |a Auromahima, Shreeman
|b 6
700 1 _ |a Bavaskar, Hiren
|b 7
700 1 _ |a Yadav, Deeksha
|b 8
700 1 _ |a Ghosh, Biplab
|0 P:(DE-He78)05807430862b6c06222f2ad5b38d95c4
|b 9
|u dkfz
700 1 _ |a Sasmal, Souvik
|b 10
700 1 _ |a Kumari, Neha
|b 11
700 1 _ |a Kumar, Tunuguntla Rishi
|b 12
700 1 _ |a Mukherjee, Ayan Prasad
|b 13
700 1 _ |a Srivastava, Sanjeeva
|0 0000-0001-5159-6834
|b 14
773 _ _ |a 10.1021/acs.jproteome.4c00982
|g p. acs.jproteome.4c00982
|0 PERI:(DE-600)2065254-9
|n 11
|p 5352-5369
|t Journal of proteome research
|v 24
|y 2025
|x 1535-3893
909 C O |p VDB
|o oai:inrepo02.dkfz.de:304985
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)05807430862b6c06222f2ad5b38d95c4
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PROTEOME RES : 2022
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-20
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-20
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l A190 Vaskuläre Onkologie und Metastasierung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21